Latest News & Features
Refine Search
Americas
If enacted by Congress, the proposed amendment to the Hatch-Waxman Act would spell trouble for generic pharmaceutical companies seeking to take on brand competitors in patent litigation, says Janine Carlan of Arent Fox. 8 August 2018
Americas
Richard Gonzalez was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 7 August 2018
Americas
Two Chinese nationals have been charged with conspiracy to steal rice technology from a US-based biotechnology company. 7 August 2018
Americas
Tony Coles was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 6 August 2018
Americas
Spain-based pharmaceutical company Almirall will acquire Allergan’s dermatology portfolio. 6 August 2018
Big Pharma
The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies. 6 August 2018
Americas
BioPharm America, to be held in Boston on September 5 and 6, 2018, will bring together startups, established companies and investors from the life sciences industry, as Kari Luu reports. 6 August 2018
Europe
German scientists claim to have developed a way of identifying counterfeit breast implants by using DNA sequences from tomatoes. 3 August 2018
Americas
Jazz Pharmaceuticals has opposed a US trademark applied for by a nutrition company to cover dietary supplements in class 5. 3 August 2018
Europe
Kim Nasmyth was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 3 August 2018